The Lucira COVID-19 All-In-One Test Kit is the First and Only FDA EUA Molecular Prescription At Home Test Kit

Only US licensed healthcare providers can purchase on this page. If you are interested in purchasing our over-the-counter product, click here.

For FDA Emergency Use Authorization (EUA) Only. For Prescription Use. For In Vitro Diagnostic (IVD) Use.

Sales from this website are with Lucira Health, the manufacturer of the FDA EUA Lucira COVID-19 All-In-One Test Kit.


Questions? Contact Customer Support

Lucira Test Kit Demonstration

Our clinical studies show 100% of users 14 and older were able to run our test.¹

¹Lucira Usability Clinical Study 07A-CLI-004/005 conducted Summer 2020 (n=352)

Latest Press Releases

Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home

FDA News Release – November 17, 2020

Lucira Technical Brief Regarding Emerging SARS-CoV-2 Strains

Lucira's Technical Brief – August 2, 2021

This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.